Bioxyne Ltd (ASX: BXN) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Bioxyne Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$15.21 million
P/E Ratio
140.85
Dividend Yield
0.00%
Shares Outstanding
1.90 billion
Earnings per share
-0.008
Dividend per share
N/A
Year To Date Return
-27.27%
Earnings Yield
0.71%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Bioxyne Ltd (ASX: BXN)
Latest News
No posts found.
BXN ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Bioxyne Ltd
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus Fermentum PCC. Some of its products include Breathe life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange etc. It operates in three segments: wholesale sales, Plant based and direct sales. The majority of the revenue is generated from Plant based in the United Kingdom, Europe and Japan.
BXN Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 18 Apr 2024 | $0.01 | $0.00 | 0.00% | 1,344,507 | $0.01 | $0.01 | $0.01 |
| 17 Apr 2024 | $0.01 | $0.00 | 0.00% | 58,548 | $0.01 | $0.01 | $0.01 |
| 16 Apr 2024 | $0.01 | $0.00 | 0.00% | 300,000 | $0.01 | $0.01 | $0.01 |
| 15 Apr 2024 | $0.01 | $0.00 | 0.00% | 1,609,522 | $0.01 | $0.01 | $0.01 |
| 12 Apr 2024 | $0.01 | $0.00 | 0.00% | 61,375 | $0.01 | $0.01 | $0.01 |
| 08 Apr 2024 | $0.01 | $0.00 | 0.00% | 50,000 | $0.01 | $0.01 | $0.01 |
| 05 Apr 2024 | $0.01 | $0.00 | 0.00% | 1,385,607 | $0.01 | $0.01 | $0.01 |
| 03 Apr 2024 | $0.01 | $0.00 | 0.00% | 3,739,459 | $0.01 | $0.01 | $0.01 |
| 02 Apr 2024 | $0.01 | $0.00 | 0.00% | 176,013 | $0.01 | $0.01 | $0.01 |
| 28 Mar 2024 | $0.01 | $0.00 | 0.00% | 1,514,825 | $0.01 | $0.01 | $0.01 |
| 27 Mar 2024 | $0.01 | $0.00 | 0.00% | 142,370 | $0.01 | $0.01 | $0.01 |
| 26 Mar 2024 | $0.01 | $0.00 | 0.00% | 119,100 | $0.01 | $0.01 | $0.01 |
| 25 Mar 2024 | $0.01 | $0.00 | 0.00% | 2,604,066 | $0.01 | $0.01 | $0.01 |
| 22 Mar 2024 | $0.01 | $0.00 | 0.00% | 9,697 | $0.01 | $0.01 | $0.01 |
| 21 Mar 2024 | $0.01 | $0.00 | 0.00% | 255,539 | $0.01 | $0.01 | $0.01 |
| 20 Mar 2024 | $0.01 | $0.00 | 0.00% | 2,707,507 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 13 Oct 2023 | Samuel Watson | Buy | 20,000,000 | $250,000 |
Off-market trade.
|
| 12 Oct 2023 | Samuel Watson | Buy | 999,362 | $14,000 |
On-market trade.
|
| 06 Oct 2023 | Anthony (Tony) Ho | Buy | 212,817 | $2,553 |
On-market trade.
|
| 06 Oct 2023 | Anthony (Tony) Ho | Buy | 500,000 | $6,000 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Anthony (Tony) Peng Ho | Non-Executive DirectorNon-Executive Chairman | Oct 2012 |
Mr Ho has corporate and financial management experience, having held Executive Director/CFO roles with several ASX listed companies in the wholesale & distribution and retail sectors. Mr Ho also previously chaired audit committees in several ASX listed companies.
|
| Mr Samuel Watson | Chief Executive OfficerManaging Director | May 2023 |
Mr Watson founded Breathe Life Sciences (BLS) in 2020 with business partner and co-director Ian Owles MPS, CFMP (certified functional medicines practitioner). BLS has quickly become a player in the health and wellness industry in Europe, UK, and Japan.
|
| Mr Jason Hine | Non-Executive Director | May 2023 |
Mr Hine was previously the GM Commercial Operations for ECS Botanics Limited, Australia's medicinal cannabis and hemp food wellness business. The ECS food and wellness business delivers quality Tasmanian grown/sourced hemp food and wellness products into the Australian grocery sector via the large grocery chains, regional distributors, and a growing bulk supply and B2C channel.
|
| Mr Guy Adrian Robertson | Company Secretary | Sep 2016 |
-
|
| Guy Adrian Robertson | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Breathe International Ltd | 576,268,527 | 30.30% |
| Global Cr Holdings Ltd | 149,050,086 | 7.84% |
| Ian Edward Owles | 132,488,966 | 6.97% |
| Kirkman Trading Ltd | 82,805,604 | 4.35% |
| Vig Limited | 80,562,003 | 4.24% |
| Bpmgmt Ltd | 79,493,379 | 4.18% |
| Nam Hoat Chua | 63,574,013 | 3.34% |
| Peng Hyang Ng | 51,500,000 | 2.71% |
| Zonetech Wellness Ltd | 37,732,857 | 1.98% |
| Paramount Star Investments Limited | 36,000,000 | 1.89% |
| Custodian Nominee Co Ltd | 34,836,169 | 1.83% |
| Andrew Alexander Ogilvie | 34,778,354 | 1.83% |
| David Buist Ogilvie | 34,778,354 | 1.83% |
| Gavin James Ogilvie | 34,778,354 | 1.83% |
| Paula Ogilvie | 34,778,354 | 1.83% |
| Mr Anthony Peng Ho & Mrs Chui Hoong Ho | 24,390,750 | 1.28% |
| Kee Siong Chia | 23,050,000 | 1.21% |
| Mr Makram Hanna & Mrs Rita Hanna <Hanna & Co P/L Super A/C> | 22,588,594 | 1.19% |
| Citicorp Nominees Pty Limited | 22,276,468 | 1.17% |
| Chun-Chieh Hsu | 20,000,000 | 1.05% |
| Global Cr Holdings Limited <Buffalo A/C> | 19,431,902 | 1.02% |
| Southam Investments 2003 Pty Ltd <Warwickshire Investment A/C> | 17,021,550 | 0.90% |
| P Ford Superannuation Pty Ltd <Patrick Ford Super Fund A/C> | 16,475,000 | 0.87% |
